Rastaldi M P, Tunesi S, Ferrario F, Indaco A, Zou H, Napodano P, D'Amico G
Renal Immunopathology Center, Division of Nephrology, San Carlo Borromeo Hospital, Milano, Italy.
Nephrol Dial Transplant. 1998 Jul;13(7):1668-74. doi: 10.1093/ndt/13.7.1668.
Among our cases of IgA glomerulonephritis (IgAGN), 10% show necrotizing/extracapillary lesions involving a small percentage of glomeruli and associated with a certain degree of inflammation in absence of glomerular and interstitial scarring. In our experience, also in repeat biopsies, these cases of IgAGN have a worse prognosis probably because necrotizing/extracapillary lesions can repeat and accumulate, leading to the progression of damage. As it is well known that transforming growth factor-beta (TGF-beta) and endothelin-1 (ET-1) are key-factors in the progression of glomerulonephritis, aim of the study was to examine their expression in renal biopsies of primary IgAGN with necrotizing/crescentic lesions in complete absence of interstitial fibrosis. To obtain information about the mitogenic effect of ET-1, the expression of c-fos, whose upregulation by ET-1 has been established in culture, was also studied.
Eighteen renal biopsies of patients with necrotizing/crescentic IgAGN were examined by immunohistochemistry with antibodies against TGF-beta, ET-1 and c-fos. The results were compared with those obtained on 22 cases of IgAGN characterized only by pure mesangial proliferation and 25 IgAGN biopsies with advanced, not active, glomerulointerstitial lesions.
In necrotizing/crescentic IgAGN glomerular TGF-beta appeared more positive than in cases characterized only by pure mesangial proliferation and was especially expressed on cellular crescents. In the interstitium, TGF-beta, ET-1 and c-fos were expressed by infiltrating leukocytes, tubules, and small vessels. This positivity, although similar as localization, was less diffuse than in biopsies with advanced interstitial damage, but significantly greater than in cases with pure mesangial proliferation.
Positivity of TGF-beta on cellular crescents is similar to that observed from other authors in different types of necrotizing/crescentic human glomerulonephritis and supports our hypothesis that this is a peculiar type of IgAGN. Moreover, interstitial expression of TGF-beta, ET-1 and c-fos in biopsies with glomerular active lesions but complete absence of interstitial fibrosis may potentially represent a signal of activation of mechanisms that induce and amplify the damage leading to further progression of the disease.
在我们的IgA肾小球肾炎(IgAGN)病例中,10%表现为坏死性/毛细血管外病变,累及一小部分肾小球,且在无肾小球和间质瘢痕形成的情况下伴有一定程度的炎症。根据我们的经验,即使在重复活检中,这些IgAGN病例的预后也较差,可能是因为坏死性/毛细血管外病变会反复出现并累积,导致损伤进展。众所周知,转化生长因子-β(TGF-β)和内皮素-1(ET-1)是肾小球肾炎进展的关键因素,本研究的目的是检测它们在完全无间质纤维化的原发性坏死性/新月体性IgAGN肾活检组织中的表达。为了获得有关ET-1促有丝分裂作用的信息,还研究了c-fos的表达,ET-1在培养中可上调其表达。
用抗TGF-β、ET-1和c-fos的抗体对18例坏死性/新月体性IgAGN患者的肾活检组织进行免疫组化检查。将结果与22例仅表现为单纯系膜增生的IgAGN病例以及25例具有晚期、非活动性肾小球间质病变的IgAGN肾活检组织的结果进行比较。
在坏死性/新月体性IgAGN中,肾小球TGF-β的阳性表现比仅以单纯系膜增生为特征的病例更明显,尤其在细胞性新月体上表达。在间质中,TGF-β、ET-1和c-fos由浸润的白细胞、肾小管和小血管表达。这种阳性表现虽然定位相似,但弥漫程度低于伴有晚期间质损伤的活检组织,但明显高于单纯系膜增生的病例。
TGF-β在细胞性新月体上的阳性表现与其他作者在不同类型的坏死性/新月体性人类肾小球肾炎中观察到的相似,支持了我们的假设,即这是一种特殊类型的IgAGN。此外,在具有肾小球活动性病变但完全无间质纤维化的活检组织中,TGF-β、ET-1和c-fos的间质表达可能潜在地代表了诱导和放大损伤并导致疾病进一步进展的机制激活信号。